Skip to main content
Erschienen in: International Urogynecology Journal 1/2010

01.01.2010 | Original Article

Validation of the Slovakian version of the P-QOL questionnaire

verfasst von: Viera Svihrova, G. Alessandro Digesu, Jan Svihra, Henrieta Hudeckova, Jan Kliment, Steven Swift

Erschienen in: International Urogynecology Journal | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

This study aimed to validate the Slovakian version of the prolapse quality-of-life (P-QOL) questionnaire.

Methods

The P-QOL questionnaire was translated into the Slovakian language and administered to women recruited from a urogynecology outpatient clinic at a tertiary referral teaching hospital. After completing a questionnaire, all women were examined in supine position using the Pelvic Organ Prolapse (POP-Q) Quantification system. The reliability was assessed by using a 2-week test–retest analysis.

Results

Fifty symptomatic and 79 asymptomatic women were included. The score of P-QOL was strongly correlated with the vaginal examination findings among the symptomatic group (p < 0.001 in eight domains). P-QOL domain scores were significantly different between symptomatic and asymptomatic women. The test–retest reliability confirmed a highly significant correlation between the total scores for each domain (p < 0.001).

Conclusion

The Slovakian version of the P-QOL questionnaire is a valid, reliable, and easily comprehensible instrument to assess quality of life of women with uterovaginal prolapse.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed
2.
Zurück zum Zitat Boyles SH, Weber AM, Myer L (2003) Procedures for pelvic organ prolapse in the United States, 1979–97. Obstet Gynecol 188:108–115CrossRef Boyles SH, Weber AM, Myer L (2003) Procedures for pelvic organ prolapse in the United States, 1979–97. Obstet Gynecol 188:108–115CrossRef
3.
Zurück zum Zitat Digesu AG, Khullar V, Cardozo L, Robinson D, Salvatore S (2005) P-QOL: a validation questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J 16:176–181CrossRef Digesu AG, Khullar V, Cardozo L, Robinson D, Salvatore S (2005) P-QOL: a validation questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J 16:176–181CrossRef
4.
Zurück zum Zitat Digesu GA, Santamato S, Khullar V, Santillo V, Digesu A, Cormio G et al (2003) Validation of an Italian version of the prolapse quality of life questionnaire. Eur J Obstet Gynecol Reprod Biol 106:184–192CrossRefPubMed Digesu GA, Santamato S, Khullar V, Santillo V, Digesu A, Cormio G et al (2003) Validation of an Italian version of the prolapse quality of life questionnaire. Eur J Obstet Gynecol Reprod Biol 106:184–192CrossRefPubMed
5.
Zurück zum Zitat de Oliveira MS, Tamanini JT, de Aguiar Cavalcanti G (2009) Validation of the prolapse quality-of-life questionnaire (P-QoL) in Portuguese version in Brazilian women. Int Urogynecol J Pelvic Floor Dysfunct 20:1191–1202. doi:10.1007/s00192-009-0934-6 de Oliveira MS, Tamanini JT, de Aguiar Cavalcanti G (2009) Validation of the prolapse quality-of-life questionnaire (P-QoL) in Portuguese version in Brazilian women. Int Urogynecol J Pelvic Floor Dysfunct 20:1191–1202. doi:10.​1007/​s00192-009-0934-6
6.
Zurück zum Zitat Lenz F, Stammer H, Brocker K, Rak M, Scherg H, Sohn C (2009) Validation of a German version of the P-QOL Questionnaire. Int Urogynecol J Pelvic Floor Dysfunct 20(6):641–649CrossRefPubMed Lenz F, Stammer H, Brocker K, Rak M, Scherg H, Sohn C (2009) Validation of a German version of the P-QOL Questionnaire. Int Urogynecol J Pelvic Floor Dysfunct 20(6):641–649CrossRefPubMed
7.
Zurück zum Zitat Cam C, Sakalli M, Ay P, Aran T, Cam M, Karateke A (2007) Validation of the prolapse quality of life questionnaire (P-QOL) in a Turkish population. Eur J Obstet Gynecol Reprod Biol 135(1):132–135CrossRefPubMed Cam C, Sakalli M, Ay P, Aran T, Cam M, Karateke A (2007) Validation of the prolapse quality of life questionnaire (P-QOL) in a Turkish population. Eur J Obstet Gynecol Reprod Biol 135(1):132–135CrossRefPubMed
8.
Zurück zum Zitat Bump RC, Mattiasson A, Bo K, Brubaker LP, Jo DeLancey, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17CrossRefPubMed Bump RC, Mattiasson A, Bo K, Brubaker LP, Jo DeLancey, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17CrossRefPubMed
9.
Zurück zum Zitat Digesu GA, Khullar V, Cardozo L, Robinson D (2008) Inter-observer reliability of digital vaginal examination using a four-grade scale in different patient positions. Int Urogynecol J Pelvic Floor Dysfunct 19:1303–1307CrossRefPubMed Digesu GA, Khullar V, Cardozo L, Robinson D (2008) Inter-observer reliability of digital vaginal examination using a four-grade scale in different patient positions. Int Urogynecol J Pelvic Floor Dysfunct 19:1303–1307CrossRefPubMed
10.
Zurück zum Zitat Lukacz ES, Lawrence JM, Buckwalter JG, Burchette RJ, Nager CHV, Luber KM (2005) Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct 16:272–284CrossRefPubMed Lukacz ES, Lawrence JM, Buckwalter JG, Burchette RJ, Nager CHV, Luber KM (2005) Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct 16:272–284CrossRefPubMed
11.
Zurück zum Zitat Srikrishna S, Robinson D, Cardozo L, Gonzalez J (2008) Is there a difference in patient and physician quality of life evaluation in pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct 19:517–520CrossRefPubMed Srikrishna S, Robinson D, Cardozo L, Gonzalez J (2008) Is there a difference in patient and physician quality of life evaluation in pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct 19:517–520CrossRefPubMed
12.
Zurück zum Zitat Tamanini JTN, Almeida FG, Girotti ME, Riccetto CLZ, Palma PCR, Rios LAS (2008) The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ. Int Urogynecol J Pelvic Floor Dysfunct 19:1385–1391CrossRefPubMed Tamanini JTN, Almeida FG, Girotti ME, Riccetto CLZ, Palma PCR, Rios LAS (2008) The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ. Int Urogynecol J Pelvic Floor Dysfunct 19:1385–1391CrossRefPubMed
13.
Zurück zum Zitat Fayyad A, Hill S, Gurung V, Prashar S, Smith ARB (2007) How accurate is symptomatic and clinical evaluation of prolapse prior to surgical repair? Int Urogynecol J Pelvic Floor Dysfunct 18:1179–1183CrossRefPubMed Fayyad A, Hill S, Gurung V, Prashar S, Smith ARB (2007) How accurate is symptomatic and clinical evaluation of prolapse prior to surgical repair? Int Urogynecol J Pelvic Floor Dysfunct 18:1179–1183CrossRefPubMed
14.
Zurück zum Zitat Digesu GA, Salvatore S, Chaliha C, Athanasiou S, Milani R, Khullar V (2007) Do overactive bladder symptoms improve after repair of anterior vaginal wall prolapse? Int Urogynecol J Pelvic Floor Dysfunct 18(12):1439–1443CrossRefPubMed Digesu GA, Salvatore S, Chaliha C, Athanasiou S, Milani R, Khullar V (2007) Do overactive bladder symptoms improve after repair of anterior vaginal wall prolapse? Int Urogynecol J Pelvic Floor Dysfunct 18(12):1439–1443CrossRefPubMed
15.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) Standardisation sub-committee of the international continence society. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 21:167–178CrossRefPubMed Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2002) Standardisation sub-committee of the international continence society. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 21:167–178CrossRefPubMed
Metadaten
Titel
Validation of the Slovakian version of the P-QOL questionnaire
verfasst von
Viera Svihrova
G. Alessandro Digesu
Jan Svihra
Henrieta Hudeckova
Jan Kliment
Steven Swift
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 1/2010
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-009-0989-4

Weitere Artikel der Ausgabe 1/2010

International Urogynecology Journal 1/2010 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.